CEO

Lodo Therapeutics
Lodo Therapeutics utilizes advanced AI models and lab automation to streamline drug discovery and development processes, providing access to high-quality datasets for researchers. The company addresses the challenges of lengthy R&D timelines and high costs in bringing new therapeutics to market.
- Agriculture Technology
- Artificial Intelligence
- Data & Analytics
- Biotechnology
Funding
Founders
Product
Problem
Traditional drug discovery and development processes are often slow, expensive, and yield limited high-quality datasets for researchers, hindering the efficient creation of new therapeutics. Lengthy R&D timelines and high costs present significant challenges in bringing innovative treatments to market.
Solution
Ginkgo Bioworks offers a platform that combines automated labs, artificial intelligence (AI) models, and biological expertise to accelerate research and development (R&D) across multiple industries. The company provides access to large, high-quality datasets and AI tools, enabling partners to streamline their R&D processes. Ginkgo's platform supports custom R&D projects, packaged services, and individual R&D tools, allowing partners to choose the solutions that best fit their needs. By leveraging Ginkgo's infrastructure, companies can overcome R&D challenges and speed up the development of new products.
Target Audience
Ginkgo Bioworks serves organizations across various sectors, including agriculture, biopharma, biosecurity, government, and industrial biotech, seeking to accelerate their R&D efforts.
Features
- Large, high-quality datasets for various applications
- AI models to accelerate data analysis and discovery
- Automated labs to streamline experimental workflows
- Custom R&D project support tailored to specific needs
- Packaged services for standardized research tasks
- R&D tools accessible via the Ginkgo Datapoints, Ginkgo AI, and Ginkgo Automation platforms
- Solutions for agriculture, biopharma, biosecurity, government, and industrial biotech sectors